Approval · Notice of Compliance 32406 · 2023
BEQVEZ: Notice of Compliance 32406
Issued December 27, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32406
- Date
- December 27, 2023
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BEQVEZ | 02544156 | Cancelled Pre Market |
Medicinal ingredients
- FIDANACOGENE ELAPARVOVEC 1,000,000 VG per ML